SCHEMBL7747445

SCHEMBL7747445

COC(=O)C=Cc1ccc(C(=O)Nc2ccncc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
MAPT P10636 2/20 0.60
LMNA P02545 3/20 0.54
POLB P06746 3/20 0.54
HPGD P15428 1/20 0.54
MAPK1 P28482 1/20 0.54
KMT2A Q03164 4/20 0.54
NT5E P21589 1/20 0.54
MEN1 O00255 3/20 0.53
ALDH1A1 P00352 1/20 0.53
PKM P14618 1/20 0.53
GAA P10253 1/20 0.53
CA12 O43570 1/20 0.53
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
TYR P14679 1/20 0.53
CA7 P43166 1/20 0.53
CA9 Q16790 1/20 0.53
CA14 Q9ULX7 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7747441 1.00 KDM4E (0.61) KDM4EL3MBTL1MAPTLMNAPOLB
SCHEMBL7005530 0.84 KDM4E (0.67) KDM4EL3MBTL1MAPTLMNAPOLB
SCHEMBL6969345 0.84 KDM4E (0.67) KDM4EL3MBTL1MAPTLMNAPOLB
SCHEMBL1232823 0.83 CA12 (0.63) KDM4EMAPTLMNAPOLBMAPK1
SCHEMBL1232824 0.83 CA12 (0.63) KDM4EMAPTLMNAPOLBMAPK1
SCHEMBL4683429 0.82 KDM4E (0.68) KDM4EMAPTLMNAHPGDKMT2A
SCHEMBL10398774 0.82 KDM4E (0.68) KDM4EMAPTLMNAHPGDKMT2A
SCHEMBL8865229 0.82 KDM4E (0.68) KDM4EMAPTLMNAHPGDKMT2A
SCHEMBL8566952 0.82 KMT2A (0.59) KDM4EL3MBTL1MAPTLMNAMAPK1
SCHEMBL8566955 0.82 KMT2A (0.59) KDM4EL3MBTL1MAPTLMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0622361-B1 Heterocyclic compounds as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO (JP) 2001-10-04 EP disclosed
US-6169095-B1 FOR PREVENTION AND/OR TREATMENT OF BRADYKININ OR ITS ANALOGUES MEDIATED DISEASES IN THE EYE, SUCH AS ALLERGY, INFLAMMATION AND PAIN OF THE EYE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
US-5922711-A ANTIALLERGENS, ANTIINFLAMMATORY AGENTS, AUTOIMMUNE DISEASES, SHOCK OR ANALGESICS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-07-13 US disclosed
EP-0596406-B1 Imidazo (1,2-a) Pyridines as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO (JP) 1998-12-16 EP disclosed
US-5750699-A HALOGENATING OF CORRESPONDING COMPOUND FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-05-12 US disclosed
US-5708173-A PREPARATION OF SUBSTITUTED QUINOLINE COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-13 US disclosed
US-5574042-A ANTAGONIST FOR BRADYKININS AS ANTIALLERGENS, AUTOIMMUNE DISEASES, ANTIINFLAMMATORY AGENTS, SHOCK OR PAIN FUJISAWA PHARMACEUTICAL CO., LTD (JP) 1996-11-12 US disclosed
US-5563162-A CAN BE ADMINISTERD FOR THE TREATMENT OF ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASES, SHOCK OR PAIN IN ANIMALS AND HUMANS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-08 US disclosed
EP-0622361-A1 Heterocyclic compounds as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-11-02 EP disclosed
EP-0596406-A1 Imidazo (1,2-a) Pyridines as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-05-11 EP disclosed